Galiellalactone

Synonyms: 肉盘菌内酯
Galiellalactone 是一种小分子真菌代谢产物,无毒且无致突变性,可作为选择性 STAT3 信号抑制剂(IC50 值为 250-500 nM),用于去势抵抗性前列腺癌的研究。
产品编号: MS-V39972 CAS No.: 133613-71-5 分子式: C11H14O3 分子量: 194.23
MolStrong 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务
规格 价格 是否有货 数量 购物车
500μg
询价
询价

产品描述

Galiellalactone 是一种小分子真菌代谢产物,无毒且无致突变性,可作为选择性 STAT3 信号抑制剂(IC50 值为 250-500 nM),用于去势抵抗性前列腺癌的研究。

生物实验数据

生物活性 Galiellalactone is a small, non-toxic, and non-mutagenic fungal metabolite that acts as a selective STAT3 signaling inhibitor with an IC50 value of 250-500 nM and can be used for the study of castration-resistant prostate cancer.
IC50 & Target STAT3:250-500 nM (IC50)
体外研究
(In Vitro)

Galiellalactone (2.5-25 μM; 24-72 hour) induces apoptosis of prostate cancer (PCa) cell lines expressingp-Stat3.
Galiellalactone (2.5-25 μM; 24-72 hour) decreases viability of DU145 cells.
Galiellalactone (10 μM) inhibits STAT3 signaling activity as assessed by luciferase reporter gene assay in IL-6-stimulated LNCaP cells.
Galiellalactone (10-100 μM; 1 hour) binds directly to STAT3 in DU145 cells.
Galiellalactone (5-50 μM; 1 hour) interferes with STAT3 DNA binding without inhibiting phosphorylation in DU145 cells.

Apoptosis Analysis

Cell Line: DU145, PC-3, and LNCaP cells
Concentration: 0, 2.5, 5, 10, 25 μM
Incubation Time: 24, 48, 72 hours
Result: Induced an apoptotic response in PC-3 and DU145 cells.

Cell Viability Assay

Cell Line: DU145 cells
Concentration: 0, 2.5, 5, 10, 17.5, 25 μM
Incubation Time: 24, 48, 72 hours
Result: Decreased DU145 cells viability in a dose- and time-dependent manner.

Western Blot Analysis

Cell Line: DU145 cells
Concentration: 0, 10, 25 μM
Incubation Time: 48 hours
Result: Induced expression of the apoptotic marker cleaved caspase-3 and increased expression of cleaved PARP.

Western Blot Analysis

Cell Line: DU145 cells
Concentration: 0, 10, 25, 50, 100 μM
Incubation Time: 1 hour
Result: Prevented the binding of the biotinylated analogue of galiellalactone (GL-biot) to STAT3 in a dose-dependent manner demonstrating competitive binding.

Western Blot Analysis

Cell Line: DU145 cells
Concentration: 0, 5, 10, 25, 50 μM
Incubation Time: 1 hour
Result: Inhibited STAT3 binding to DNA in a dose-dependent manner.
Did not affect phosphorylation of STAT3 Tyr-705 and Ser-727 or the expression of total STAT3.
体内研究
(In Vivo)

Galiellalactone (1, 3 mg/kg; daily i.p. for 3 weeks) inhibits PCa tumor growth in vivo.

Animal Model: Male nude NMR1 mice are injected PCa cell
Dosage: 0, 1, 3 mg/kg
Administration: Daily i.p. injections for 3 weeks
Result: Reduced the tumor growth rate in DU145 xenografts by 41-42% and was well tolerated.
性状 固体
颜色 White to off-white

化学信息

分子量 194.23
分子式 C11H14O3
CAS No. 133613-71-5
别名 肉盘菌内酯

储存&溶解度

溶解度信息
Ethanol: Soluble
DMSO: Soluble
储存方式
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
运输条件 Room temperature in continental US; may vary elsewhere.

计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
起始浓度(M)× 起始体积(L)= 最终浓度(M)× 最终体积(L)
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
溶液体积 = 质量 ÷ 配液浓度
Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration
÷
分子量计算器
Enter the chemical formula of the compound to calculate its molar mass and elemental composition
g/mol

体内实验配液计算器

动物实验计算换算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:

比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL, 一共给药动物10只,您使用的配方为 10% DMSO + 40% PEG300 + 5% Tween 80 + 45% Saline / PBS / ddH2O, 那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 100 μL DMSO ( 母液浓度为 20 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法: 取 100 μL DMSO 母液, 添加 400 μL PEG300 混匀澄清, 再加 50 μL Tween 80, 混匀澄清, 再加 450 μL Saline / PBS / ddH2O 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

方案所需的各类助溶剂如: DMSO, PEG300, PEG400, Tween 80, SBE-β-CD, 玉米油等, 均可在MolStrong网站点击购买。

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度: mg/ml;

DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础